BridgeBio Pharma Inc (BBIO) — Quality & forensics
As of 2026-11-10 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 11
- Quality 21
- Growth 76
- Balance sheet 27
- Cash quality 34
- Capital allocation 21
- Momentum 55
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.
Continue: the BBIO chart & overview · the earnings record
FAQ · from the current data · as of 2026-11-10
Quick answers
What is BridgeBio Pharma Inc's Closelooknet quality reading?
The composite reads 36/100 across 7 modules, as of 2026-11-10: valuation 11, quality 21, growth 76, balance sheet 27, cash quality 34, capital allocation 21, momentum 55. Closelooknet scores are research diary readings, not ratings or investment advice.
What is BridgeBio Pharma Inc's Altman Z-Score?
-3.57, which sits in the distress zone (below 1.81) as of 2026-11-10. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is BridgeBio Pharma Inc's Piotroski F-Score?
2 of 9, as of 2026-11-10. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does BridgeBio Pharma Inc's Beneish M-Score indicate?
8.31 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-11-10. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeOne Medicines AGindustry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry
- XNCR Xencor Incindustry
- VCEL Vericel Corp Ordindustry
- VRDN Viridian Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- MRNA Moderna Incindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- ORKA Oruka Therapeutics, Inc.industry
- ADMA ADMA Biologics Incindustry
- PHARM.AS Pharming Group NVindustry
- MEDCL.PA Medincell SAindustry
- DNA Ginkgo Bioworks Holdingsindustry
- NEU.AU Neuren Pharmaceuticals Ltdindustry